159 related articles for article (PubMed ID: 27189620)
1. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer.
Kocher NJ; Rjepaj C; Robyak H; Lehman E; Raman JD
World J Urol; 2017 Jan; 35(1):67-72. PubMed ID: 27189620
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma is more aggressive in Turkish patients with the metabolic syndrome.
Ozbek E; Otunctemur A; Sahin S; Dursun M; Besiroglu H; Koklu I; Polat EC; Erkoc M; Danis E; Bozkurt M
Asian Pac J Cancer Prev; 2013; 14(12):7351-4. PubMed ID: 24460301
[TBL] [Abstract][Full Text] [Related]
3. Incidence and histologic features of mixed renal tumors.
Kocher NJ; Rjepaj C; Lehman E; Raman JD
J Surg Oncol; 2018 Mar; 117(3):430-433. PubMed ID: 29044535
[TBL] [Abstract][Full Text] [Related]
4. A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC).
Choi SM; Choi DK; Kim TH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
PLoS One; 2015; 10(3):e0122019. PubMed ID: 25799553
[TBL] [Abstract][Full Text] [Related]
5. Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically.
Vilaseca A; Nguyen DP; Vertosick EA; Corradi RB; Musquera M; Pérez M; Fossati N; Sjoberg DD; Farré R; Almendros I; Montserrat JM; Benfante NE; Hakimi AA; Skanderup AJ; Russo P; Alcaraz A; Touijer KA
World J Urol; 2017 Jan; 35(1):51-56. PubMed ID: 27108420
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.
Kriegmair MC; Mandel P; Porubsky S; Dürr J; Huck N; Nuhn P; Pfalzgraf D; Michel MS; Wagener N
Horm Cancer; 2017 Apr; 8(2):127-134. PubMed ID: 28247362
[TBL] [Abstract][Full Text] [Related]
7. Components of metabolic syndrome and prognosis of renal cell cancer.
Eskelinen TJ; Kotsar A; Tammela TLJ; Murtola TJ
Scand J Urol; 2017 Dec; 51(6):435-441. PubMed ID: 28743221
[TBL] [Abstract][Full Text] [Related]
8. Renal lesions with low R.E.N.A.L nephrometry score are associated with more indolent renal cell carcinomas (RCCs) or benign histology: findings in an Australian cohort.
Satasivam P; Sengupta S; Rajarubendra N; Chia PH; Munshey A; Bolton D
BJU Int; 2012 Apr; 109 Suppl 3():44-7. PubMed ID: 22458493
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma.
Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Stolzenbach F; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Urology; 2020 Jun; 140():91-97. PubMed ID: 32151650
[TBL] [Abstract][Full Text] [Related]
10. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
11. An obese body habitus does not preclude a minimally invasive partial nephrectomy.
Reynolds C; Hannon M; Lehman K; Harpster LE; Raman JD
Can J Urol; 2014 Feb; 21(1):7145-9. PubMed ID: 24529018
[TBL] [Abstract][Full Text] [Related]
12. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
13. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.
Zhang C; Li X; Hao H; Yu W; He Z; Zhou L
BJU Int; 2012 Dec; 110(11 Pt B):E481-5. PubMed ID: 22540142
[TBL] [Abstract][Full Text] [Related]
14. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
15. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
[TBL] [Abstract][Full Text] [Related]
16. Renal tumour anatomical characteristics and functional outcome after partial nephrectomy.
Nisen H; Heimonen P; Kenttä L; Visapää H; Nisen J; Taari K
Scand J Urol; 2015 Jun; 49(3):193-9. PubMed ID: 25385687
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014.
Bai T; Wang L; Wang D; Yuan X; Bai W; Yang Q; Yang X
PLoS One; 2015; 10(12):e0144246. PubMed ID: 26633179
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
